NCT01668849View on ClinicalTrials.gov

Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 2, 2012

Primary Completion Date

May 25, 2022

Study Completion Date

June 3, 2022

Conditions
Head and Neck CancerOral Mucositis
Interventions
DIETARY_SUPPLEMENT

Grape extract

Grape extract self-administered by mouth daily for 35 days

DRUG

Lortab, Fentanyl patch, mouthwash

Lortab 5-10 mg Fentanyl patch 25 mcgs Mary's Magic Mouthwash

Trial Locations (1)

40202

James Graham Brown Cancer Center, Louisville

All Listed Sponsors
collaborator

James Graham Brown Cancer Center

OTHER

lead

University of Louisville

OTHER

NCT01668849 - Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer | Biotech Hunter | Biotech Hunter